Aster DM Healthcare (NSE:ASTERDM, BOM:540975) has received approval from the Competition Commission of India for its proposed merger with Quality Care India, according to a Wednesday filing to the Indian stock exchanges.
The transaction also includes Quality Care India's private equity investors and shareholders- BCP Asia II TopCo IV and Centella Mauritius Holdings.
Before the merger, Aster will purchase a 5% stake in Quality Care India from BCP Asia and Mauritius Holdings. This transaction will be in consideration of a primary share issuance by Aster, the competition watchdog said in a separate statement.
On completion of the merger, investors including BCP Asia, Mauritius Holdings and some minority stakeholders, will hold a certain stake in the merged entity. However, Mauritius Holdings will have a less than 10% stake without control rights in Aster DM Quality Care.
The company's shares were up 2% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。